Human Papillomavirus

Diagnostics company received CE mark for Linear Array HP Genotyping Test

Published in OBGYN and Reproduction Week, July 25th, 2005

Roche Diagnostics announced that it has received CE Mark certification for its new Linear Array HPV Genotyping Test, allowing Roche Diagnostics to sell the test in the European Union and other countries that accept CE Mark certification.

This test identifies 37 high- and low-risk human papillomavirus (HPV) genotypes, including those considered a significant risk factor for progression to cervical cancer. The test is the first HPV genotyping test kit to be registered for in vitro diagnostic use.

The accurate identification of high-risk HPV genotypes is a major step forward in defining a woman's risk of progression to cervical cancer. The Linear Array...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week

Source: OBGYN and Reproduction Week (2005-07-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry